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provocation can be reduced by apocynin. However, the protein expression of NADPH
oxidase’s subunit, p22phox and gp91phox have no signiﬁcant difference among all
the groups. Regarding the MAPK pathway, the phosphorylation level of JNK 1 and
p38 are up-regulated and apocynin can reduce the protein expression levels of their
phosphorylation (P<0.01). The downstream ﬁbrosis-related protein MMP9 is over-
expressed by up-mentioned stimulation and can be reduced by apocynin (P<0.05).
Conclusions: High concentration of glucose and H2O2 promote the proliferation of
atrial ﬁbroblast and the combined stimulus has more remarkable effects. Similarly to
the mechanism of H2O2, glucose enhances the expression of ﬁbrosis-related protein
MMP 9 through up-regulating the function of NADPH oxidase and the expression and
phosphorylation level of JNK 1 and p38. Apocynin, a NADPH oxidase inhibitor, can
reduce the up-regulation of NADPH oxidase/MAPK/MMP 9 signal pathway and
suppress the abnormal proliferation of atrial ﬁbroblast.
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Objectives: NF-kB signaling plays a central role in the regulation of inﬂammatory re-
sponses in atherosclerosis. To our knowledge, it is less intensively studied whether R65
ribozyme gene can decrease the expression of NF-kB pathway. Therefore, we used a
recombinant adeno-associated virus serotype 9 vector to deliver the R65 ribozyme gene
(rAVV9-R65) into oxidized LDL (ox-LDL) induced human umbilical vein endothelial
cells (HUVECs).We also assessedwhether rAAV9vector-mediatedR65 ribozyme gene
transfection can be expressed for a longterm and inhibit the activity of NF-kB.
Methods: rAVV9-R65 was transfected into HUVECs at different multiplicities of
infection, which was measured by ﬂow cytometry.The activity of NF-kB pathway was
analyzed by Western blot and Immunoﬂuorescencestaining.NF-kB inﬂammatory
factors and endothelial cell function markers were measured by ELISA. Cell apoptosis
was detected by Flow cytometry.
Results: The effects of the rAVV9-R65 upon ox-LDL induced injury of the HUVECs
were evaluated. First, rAVV9-R65 was transfected into HUVECs at different multi-
plicities of infection and it could be stably and efﬁciently expressed. Second, ox-LDL
led to concurrent increased NF-kB expression in a dose- and time-dependent manner,
and it increased inﬂammatory factors (TNF-a, IL-6) and cell apoptosis in HUVECs.
Third, over-expression of rAVV9-R65 gene could inhibit the NF-kB pathway and
protect HUVECs against ox-LDL induced cell apoptosis.
Conclusions: These results demonstrate thatAAV9-mediated R65 ribozyme gene
transfection may inhibit the expression of NF-kBand consequently down-regulate the
expression of downstream components of NF-kB and its transcription factors.
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Objectives: Adipose tissue receptors C5aR and C5L2 and their heterodimerization/
functionality and interaction with ligands C5a and acylation stimulating protein (ASP)
have been evaluated in cell and rodent studies. Their contribution to coronary artery
disease (CAD) factors in humans remains unclear. We hypothesized that C5a
receptors, classically required for host defense, are also associated with CAD.
Methods: Anthropometry and fasting blood parameters were measured in 492 CAD
patients and 577 control subjects.
Results: C5L2 gene Heterozygote carriers of the CT genotype were more frequent
among CAD patients than among controls (7.3% versus 1.7%). The odds ratio (OR) for
carriers of the CT genotype for CAD was 4.484 (95% conﬁdence interval (CI) :
2.197-9.174). C5aR gene Heterozygote carriers of the CT genotype were more frequent
among CAD patients than among controls (4.7%versus1.6%). The odds ratio (OR) for
carriers of the 698CT genotype for CAD was 4.484 (95% conﬁdence interval (CI) :
2.197-9.174), C5a gene Omental C5L2/C5a Rratio increased with BMI (P<0.01) with
correlations between C5L2/C5aR and waist circumference, HDL-C, and adiponectin.
Conclusions: Suggest relationship to The CT genotype of C5L2 and C5aR gene may
be a genetic maker of CAD and highlight adipose-immune interactions.
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gene polymorphisms (rs2298423 and rs6986132) and association with serum lipid in
Han and Uighur populations in Xinjiang.
Methods: The genotypes of the ADRB3 gene were detected in 362 Uighur and 653
Han healthy individuals by real-time PCR (TaqMan).
Results: (1) The frequencies of TT, GTand GG genotypes of the rs2298423 locus
were 76.5%,22.1% and 1.4% in the Uighurs, and 74.7%,23.3% and 2.0% in the
Hans.There was no signiﬁcant difference in distribution of genotypes between the two
populations (P¼0.695); (2) The frequencies of GG,AG and AA genotypes of the
rs6986132 locus were 81.5%,16.6% and 1.9% in Uighurs, and 59.6%,33.7% and 6.7%
in Hans.There was signiﬁcant difference in distribution of genotypes between the two
populations (P<0.001); (3) Total cholesterol and low density lipoprotein cholesterol
level were signiﬁcantly higher in GG or GT genotype than in TT genotype carrier of
rs2298423 in Uighur individuals, but not in Han populations. The serum lipid level
which include TC, LDL-C, TG, HDL-C were no signiﬁcant difference in distribution
of rs6986132genotypes between the two populations. After adjusting for gender,
age, height, weight, waist circumference, blood urea nitrogen, creatinine, glucose,
triglyceride, smoking, drinking, logistic regression analyses revealed that individuals
carrying GG or GT genotype of rs2298423 face an increased risk for total cholesterol
and low density lipoprotein cholesterol level than individuals carrying TT genotype in
Uighur populations (OR¼3.140,95%CI:1.270-7.764 in TC level, OR¼3.818,95%
CI:1.761-8.280 in LDL-C level); (4) The T-G haplotype was more frequent in the
Uighur but the T-A haplotype was more common in the Han population, respectively
(both P<0.001).
Conclusions: The mutational frequencies of the tagging SNPs in rs2298423 and
rs6986132 loci of the ADRB3 gene have obvious differences in Chinese Han and
Uighur populations of Xinjiang. G allele carriers of rs2298423 face an increased risk
for total cholesterol and low density lipoprotein cholesterol level in Uighur pop-
ulations in Xinjiang.
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Objectives: Serum amyloid A protein (SAA) is not only an inﬂammatory factor but
also an apolipoprotein that can replace apolipoprotein A1 (apoA1) as the major
apolipoprotein of HDL. However, the relationship between genetic polymorphisms of
SAA and coronary artery disease (CAD) remains unclear.
Methods: 4 Single Nucleotide Polymorphisms (rs12218, rs4638289, rs7131332, and
rs11603089) of SAA gene were genotyped by use of polymerase chain reaction -
restriction fragment length polymorphism (PCR - RFLP) method in two independent
case-control studies: one was in the Han population (1 416 CAD patients and 1 373
control subjects) and the other was in the Uygur population (588 CAD patients and
529 control subjects).
Results: We found rs12218 CC genotype were more frequent among CAD patients
than among controls not only in the Han population (8.3% versus 4.8%, P<0.001) but
also in the Uygur population (15.5% versus 11.3%, P<0.05). After adjustment of
confounding factors such as sex, age, smoking, drinking, hypertension, diabetes,
serum levels of triglyceride, total cholesterol, high density lipoprotein, the difference
remained signiﬁcant in the Han group (P<0.001, OR¼5.906, 95% CI: 2.877-12.124)
and in the Uygur group (P¼0.026, OR¼3.288, 95% CI: 1.015-6.671).
Conclusions: Genetic polymorphisms of SAA1 may be a genetic maker of CAD in
the Han and Uygur population in western China.
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Objectives: This study aimed to investigate whether acute or chronic administration
of the Resveratrol (3, 5, 4’-trihydroxystilbene) affect the cardioprotective effects of
ischemic postconditioning (Ipost) in diabetic and non-diabetic rat hearts.
Methods: Isolated rat hearts were subjected to 30 min of global ischemia, followed by
120 min of reperfusion. The hearts were subjected to the following treatments: non-
conditioning, Ipost (six cycles of 10-s reperfusion-ischemia after ischemia), acute
Resveratrol (10 mmol/l Resveratrol during reperfusion), acute Resveratrol with Ipost,
chronic Resveratrol (10 mg/kg/day Resveratrol for 2 weeks), and chronic Resveratrol
with Ipost. Infarct size, haemodynamics and expression of Akt and eNOS were
examined.
Results: Our results show that Ipost did not limit infarct size and recover contractile
dysfunction in the hearts of diabetic rats (infarct size: 58.1% and 59.2%, P>0.05).
Acute Resveratrol treatment with Ipost resulted in infarct size-limiting and contractile
dysfunction-recovering effects in both diabetic and non-diabetic hearts (infarct size:
38.8% and 59.2% in diabetic ones and 24.3% and 43.7% in non-diabetic ones, P<0.05,
respectively), and produced a further activation of Akt and eNOS signaling pathways toer 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
enhance these protective effects in the hearts of diabetic rats. Chronic Resveratrol
treatment with Ipost neither reduced infarct size nor increased myocardial dysfunction
recovery in both diabetic and non-diabetic rats (infarct size: 59.5% and 59.2% in
diabetic ones and 45.0% and 43.7% in non-diabetic ones, P>0.05, respectively), and
this might be associated with an inhibition of Akt and eNOS phosphorylation.
Conclusions: The combination of acute Resveratrol treatment with Ipost shows a
stronger protective effect within the hearts of diabetic rats, but chronic Resveratrol
with Ipost fails to protect hearts against reperfusion injury in either diabetic or non-
diabetic rat hearts. These ﬁndings will be important for the design of future clinical
investigations.
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Objectives: Our studies demonstrate that deletion of the transient receptor potential
vanilloid type 1 (TRPV1) gene aggravates deoxycorticosterone acetate (DOCA) -salt
hypertension-induced renal injury, which is associated with increased intra-renal
monocyte/macrophage inﬁltration and inﬂammation. The results suggest that TRPV1
may act as a potential regulator of monocyte/macrophage inﬁltration to reduce renal
injury in DOCA-salt hypertension. Therefore, this study was designed to test the
hypothesis that deletion of TRPV1 exaggerates salt-sensitive hypertension-induced
renal injury via activation of chemokine receptor 2 (CCR2).
Methods:We induced salt-sensitive hypertension for 4 weeks by uninephrectomy and
DOCA-salt in wild type (WT) and TRPV1-null mutant (TRPV1-/-) mice with or
without the selective CCR2 antagonist, RS504393.
Results: DOCA-salt treatment increased systolic blood pressure (SBP) to the same
degree in both strains, but increased urinary excretion of albumin and 8-isoprostane
and decreased creatinine clearance with greater magnitude in TRPV1-/- mice
compared to WT mice (89.35.2 vs. 26.53.4 mg/24h; 4.240.45 vs. 1.520.21
ng/24h; 9819 vs. 16814 ml/24h, P<0.05). DOCA-salt treatment also caused
renal glomerulosclerosis, tubulointerstitial injury, collagen deposition, monocyte/
macrophage inﬁltration, proinﬂammatory cytokine and chemokine production,
and NF-kB activation in greater degree in TRPV1-/- mice compared to WT
mice (glomerulosclerosis index: 0.780.15 vs. 0.350.14; tubulointerstitial injury
score: 3.371.0 vs. 2.010.49; collagen content: 21.82.3 vs. 13.82.4 mg/mg dry
tissue; monocyte/macrophage inﬁltration: 744 vs. 425 cells/mm2; TNF-a:
1.030.22 vs. 0.760.21 pg/mg protein; MCP-1: 10.351.19 vs. 6.000.86 pg/mg
protein; p65-NF-kB protein: 545 vs. 363 ng/mg protein, P<0.05). Blockade of
the CCR2 with RS504393 (4 mg/kg) had no effect on SBP in DOCA-salt-treated
WT or TRPV1-/- mice compared to their respective controls. However, treatment
with RS504393 ameliorated renal dysfunction and morphological damage, and
prevented the increase in monocyte/macrophage inﬁltration, cytokine/chemokine
production, and NF-kB activity in both DOCA-salt hypertensive strains with a
greater effect in DOCA-salt-treated TRPV1-/- compared to DOCA-salt-treated
WT mice.
Conclusions: Our study showed that blockade of CCR2 with RS504393
attenuated DOCA-salt hypertension-induced renal injury in WT and TRPV1-/- mice
independently of their effects on blood pressure. The protective effect was greater in
TRPV1-/- mice compared to WT mice. The results suggest that deletion of TRPV1
aggravated salt-sensitive hypertension-induced renal damage possibly via activation of
the MCP-1/CCR2 signaling pathway. [This work was supported by a grant from the
National Natural Science Foundation of China (No. 81170243)].
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Objectives: It has been reported that the induction of heme oxygenase-1 (HO-1)
mediated by b1-adrenergic receptor inhibits high mobility group box 1 protein
(HMGB1) release and increases the survival rate in cecal ligation and puncture-
induced septic mice. The present study aimed to investigate whether dobutamine, a
selective b1-adrenergic receptor agonist, could inhibit HMGB1 release via
b1-adrenergic receptor-mediated HO-1 induction and attenuate myocardial ischemia/
reperfusion (I/R) injury in rats.
Methods: Anesthetized male rats were pretreated with dobutamine (5 or 10
microg.Kg-1. min-1, intravenous) before ischemia in the absence and/or presence of
LY294002 (0.3 mg/Kg), a phosphatidylinositol 3-kinase (PI3K) inhibitor; SB203580
(1 mg/Kg), a p38 mitogen-activated-protein kinase (P38 mitogen-activated-protein
kinase [p38 MAPK]) inhibitor, and zinc protoporphyrin IX ([ZnPPIX], 10 mg/Kg), a
HO-1 inhibitor, respectively, and then subjected to ischemia for 30 min followed by
reperfusion for 4 h. The myocardial I/R injury and oxidative stress were assessed.
Likewise, the expressions of HO-1 protein, nuclear factor kappa B (NF-kappaB) p65,
and HMGB1 were measured by Western blot analysis.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BResults: After 4 h reperfusion, compared with I/R group, the pretreatment of
dobutamine signiﬁcantly reduced the infarct size in a dose-dependent manner, and the
increase of LDH and CK levels were signiﬁcantly inhibited by dobutamine (both
P<0.05 versus I/R group). Meanwhile, dobutamine dose-dependently reduced
oxidative stress by inhibiting the increase of the MDA level and the decrease of the
SOD level (both P<0.05 versus I/R group). Otherwise, dobutamine produced a sta-
tistically signiﬁcant reduction in the production of TNF-a and IL-6 compared with the
I/R group (both P<0.05 versus I/R group). Furthermore, compared with I/R group,
dobutamine signiﬁcantly and dose-dependently mediated HO-1 induction and
NF-kappaB p65 and HMGB1 inhibition (all P<0.05 versus I/R group). However, all
the effects caused by dobutamine were signiﬁcantly reversed by the presence of
LY294002, SB203580, and ZnPPIX, respectively.
Conclusions: The present study demonstrated that dobutamine mediated the induction
of HO-1 by selectively stimulating b1-adrenergic receptor via PI3K and p38 MAPK,
which inhibited HMGB1 release and attenuated rat myocardial I/R injury in vivo.
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Objectives: Human Cytochrome P450 2J2 (CYP2J2) is the major arachidonic acid
epoxygenase, which can metabolizes arachidonic acid (AA) to biologically active
epoxyeicosatrienoic acids (EETs). The EETs are potent endogenous vasodilators and
inhibitors of vascular inﬂammation. Recently, much evidence from models and human
studies suggests that variability of CYP2J2 gene plays a mechanistic role in the
development of hypertension. The aim of the present study was to assess the asso-
ciation between the human CYP2J2 gene polymorphism and Essential Hypertension
(EH) in a Han and Uygur population in China.
Methods: We used two independent case-control studies: a Han population (302 EH
patients and 300 control subjects) and a Uygur population (567 EH patients and 215
control subjects). All EH patients and controls were genotyped for the same three
single nucleotide polymorphisms (SNPs) (rs890293, rs11572223 and rs2280275) of
CYP2J2 gene by a Real-time PCR instrument.
Results: In the Uygur population, the distribution of SNP3 (rs2280275) genotypes,
alleles and the dominant model (CC vs CT + TT) showed a signiﬁcant difference
between EH and control participants (for genotype: P¼0.007; for allele: P¼0.001; for
dominant model: P¼0.002). The signiﬁcant difference in dominant model was retained
after adjustment for covariates (OR: 3.500, 95% conﬁdence interval [CI]: 1.680-7.300,
P¼0.001). However, all the above differences were not shown in the Han population.
Conclusions: The CC genotype of rs2280275 in CYP2J2 gene could be a risk genetic
marker of EH and T allele may be a protective genetic marker of EH in Uygur
population in China.
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Objectives: Recent studies demonstrated that endothelial-derived microRNAs
(miRNAs) can be detected in clinical plasma/serum samples, and there are also evi-
dences indicated that inﬂammation disease states (e.g., atherosclerosis, cancer, etc.)
may affect the levels of circulating miRNAs, but so far there is no direct proof about
whether inﬂammation could induce endothelial cells to release miRNAs into circu-
lation.This study aimed to explore whether inﬂammation could induce endothelial
cells to release miRNAs into circulation and to investigate whether these released
miRNAs derived from endothelial cells were transported in microparticles.
Methods: Microparticles were isolated from human atherosclerotic plaques with an
active inﬂammatory phenotype and normal vascular tissue. Endarteretomy specimens
constituting the intima and inner media of carotid atherosclerotic regions were
obtained from the patients underwent carotid endarteretomy (CEA) (n¼9). Patients
undergoing coronary artery bypass surgery (CABG) procedure (n¼9) were included
as controls and the whole thickness vascular rings of normal vascular tissue (LIMA)
were obtained. Flow cytometry and real time PCR were used to detect the levels of
microparticles and microRNAs. To investigate whether these upregulated ECs-
enriched miRNAs levels in the MPs isolated from atherosclerotic plaques were caused
by inﬂammatory stimuli, human umbilical vein endothelial cells (HUVEC) were
treated with TNF-a (TNF-a group, n¼3) or DMEM (control group, n¼3) for 24
hours. and then HUVEC and the culture medium were respectively collected.
Results: By comparing microparticles isolated from human atherosclerotic plaques
with an active inﬂammatory phenotype (n¼9) and those from normal vascular tissues
(n¼9), we found levels of annexin V+ microparticles and annexin V+ CD144+
microparticles were signiﬁcantly increased in plaques (P <0.001) and angiogenesis-
associated miRNAs (106b, 25, 92a and 21) were also signiﬁcantly increased in
microparticles from plaques (P <0.05). After exposure to TNF-a at a concentration of
10 ng/ml (TNF-a group, n¼3) or DMEM (control group, n¼3) for 24 hours, counts of
microparticles and expressions of miRNAs-106b, 25, 92a and 21 in microparticlesasic and Translational Medicine C9
